Health and health care; personal characteristics, 2014-2021

Edit table Show description

Health and health care; personal characteristics, 2014-2021
Characteristics persons Margins Periods Chronic disorders Disorders in the last 12 months Stroke, cerebral haemorrhage/infarction (%) Chronic disorders Chronic disorders, ever had Stroke, cerebral haemorrhage/infarction (%) SF-12 health measure, age 12 or older Norm score physical (number) SF-12 health measure, age 12 or older Norm score Psychological (number)
Age: 0 to 3 years Value 2014 . . . .
Age: 0 to 3 years Value 2015 . . . .
Age: 0 to 3 years Value 2016 . . . .
Age: 0 to 3 years Value 2017 . . . .
Age: 0 to 3 years Value 2018 . . . .
Age: 0 to 3 years Value 2019 . . . .
Age: 0 to 3 years Value 2020 . . . .
Age: 0 to 3 years Value 2021 . . . .
Age: 0 to 3 years Lower bound 95% confidence interval 2014 . . . .
Age: 0 to 3 years Lower bound 95% confidence interval 2015 . . . .
Age: 0 to 3 years Lower bound 95% confidence interval 2016 . . . .
Age: 0 to 3 years Lower bound 95% confidence interval 2017 . . . .
Age: 0 to 3 years Lower bound 95% confidence interval 2018 . . . .
Age: 0 to 3 years Lower bound 95% confidence interval 2019 . . . .
Age: 0 to 3 years Lower bound 95% confidence interval 2020 . . . .
Age: 0 to 3 years Lower bound 95% confidence interval 2021 . . . .
Age: 0 to 3 years Upper bound 95% confidence interval 2014 . . . .
Age: 0 to 3 years Upper bound 95% confidence interval 2015 . . . .
Age: 0 to 3 years Upper bound 95% confidence interval 2016 . . . .
Age: 0 to 3 years Upper bound 95% confidence interval 2017 . . . .
Age: 0 to 3 years Upper bound 95% confidence interval 2018 . . . .
Age: 0 to 3 years Upper bound 95% confidence interval 2019 . . . .
Age: 0 to 3 years Upper bound 95% confidence interval 2020 . . . .
Age: 0 to 3 years Upper bound 95% confidence interval 2021 . . . .
Age: 4 to 11 years Value 2014 . . . .
Age: 4 to 11 years Value 2015 . . . .
Age: 4 to 11 years Value 2016 . . . .
Age: 4 to 11 years Value 2017 . . . .
Age: 4 to 11 years Value 2018 . . . .
Age: 4 to 11 years Value 2019 . . . .
Age: 4 to 11 years Value 2020 . . . .
Age: 4 to 11 years Value 2021 . . . .
Age: 4 to 11 years Lower bound 95% confidence interval 2014 . . . .
Age: 4 to 11 years Lower bound 95% confidence interval 2015 . . . .
Age: 4 to 11 years Lower bound 95% confidence interval 2016 . . . .
Age: 4 to 11 years Lower bound 95% confidence interval 2017 . . . .
Age: 4 to 11 years Lower bound 95% confidence interval 2018 . . . .
Age: 4 to 11 years Lower bound 95% confidence interval 2019 . . . .
Age: 4 to 11 years Lower bound 95% confidence interval 2020 . . . .
Age: 4 to 11 years Lower bound 95% confidence interval 2021 . . . .
Age: 4 to 11 years Upper bound 95% confidence interval 2014 . . . .
Age: 4 to 11 years Upper bound 95% confidence interval 2015 . . . .
Age: 4 to 11 years Upper bound 95% confidence interval 2016 . . . .
Age: 4 to 11 years Upper bound 95% confidence interval 2017 . . . .
Age: 4 to 11 years Upper bound 95% confidence interval 2018 . . . .
Age: 4 to 11 years Upper bound 95% confidence interval 2019 . . . .
Age: 4 to 11 years Upper bound 95% confidence interval 2020 . . . .
Age: 4 to 11 years Upper bound 95% confidence interval 2021 . . . .
Age: 12 to 15 years Value 2014 0.0 0.0 . .
Age: 12 to 15 years Value 2015 0.0 0.3 . .
Age: 12 to 15 years Value 2016 0.0 0.5 . .
Age: 12 to 15 years Value 2017 0.0 0.1 . .
Age: 12 to 15 years Value 2018 0.2 0.2 . .
Age: 12 to 15 years Value 2019 0.0 0.0 . .
Age: 12 to 15 years Value 2020 0.0 0.0 54.6 53.4
Age: 12 to 15 years Value 2021 0.0 0.0 54.5 51.6
Age: 12 to 15 years Lower bound 95% confidence interval 2014 0.0 0.0 . .
Age: 12 to 15 years Lower bound 95% confidence interval 2015 0.0 0.0 . .
Age: 12 to 15 years Lower bound 95% confidence interval 2016 0.0 0.0 . .
Age: 12 to 15 years Lower bound 95% confidence interval 2017 0.0 0.0 . .
Age: 12 to 15 years Lower bound 95% confidence interval 2018 0.0 0.0 . .
Age: 12 to 15 years Lower bound 95% confidence interval 2019 . . . .
Age: 12 to 15 years Lower bound 95% confidence interval 2020 . . 54.1 52.5
Age: 12 to 15 years Lower bound 95% confidence interval 2021 . . 54.1 50.6
Age: 12 to 15 years Upper bound 95% confidence interval 2014 0.0 0.0 . .
Age: 12 to 15 years Upper bound 95% confidence interval 2015 0.0 0.7 . .
Age: 12 to 15 years Upper bound 95% confidence interval 2016 0.0 1.2 . .
Age: 12 to 15 years Upper bound 95% confidence interval 2017 0.0 0.5 . .
Age: 12 to 15 years Upper bound 95% confidence interval 2018 0.7 0.7 . .
Age: 12 to 15 years Upper bound 95% confidence interval 2019 . . . .
Age: 12 to 15 years Upper bound 95% confidence interval 2020 . . 55.0 54.2
Age: 12 to 15 years Upper bound 95% confidence interval 2021 . . 55.0 52.6
Age: 16 to 19 years Value 2014 0.0 0.2 . .
Age: 16 to 19 years Value 2015 0.0 0.3 . .
Age: 16 to 19 years Value 2016 0.0 0.0 . .
Age: 16 to 19 years Value 2017 0.0 0.7 . .
Age: 16 to 19 years Value 2018 0.3 0.3 . .
Age: 16 to 19 years Value 2019 0.5 0.5 . .
Age: 16 to 19 years Value 2020 0.0 0.5 53.8 50.0
Age: 16 to 19 years Value 2021 0.0 0.6 54.4 48.5
Age: 16 to 19 years Lower bound 95% confidence interval 2014 0.0 0.0 . .
Age: 16 to 19 years Lower bound 95% confidence interval 2015 0.0 0.0 . .
Age: 16 to 19 years Lower bound 95% confidence interval 2016 0.0 0.0 . .
Age: 16 to 19 years Lower bound 95% confidence interval 2017 0.0 0.0 . .
Age: 16 to 19 years Lower bound 95% confidence interval 2018 0.0 0.0 . .
Age: 16 to 19 years Lower bound 95% confidence interval 2019 0.0 0.0 . .
Age: 16 to 19 years Lower bound 95% confidence interval 2020 . 0.0 53.3 49.1
Age: 16 to 19 years Lower bound 95% confidence interval 2021 . 0.1 53.8 47.2
Age: 16 to 19 years Upper bound 95% confidence interval 2014 0.0 0.6 . .
Age: 16 to 19 years Upper bound 95% confidence interval 2015 0.0 0.8 . .
Age: 16 to 19 years Upper bound 95% confidence interval 2016 0.0 0.0 . .
Age: 16 to 19 years Upper bound 95% confidence interval 2017 0.0 1.5 . .
Age: 16 to 19 years Upper bound 95% confidence interval 2018 0.7 0.7 . .
Age: 16 to 19 years Upper bound 95% confidence interval 2019 1.1 1.1 . .
Age: 16 to 19 years Upper bound 95% confidence interval 2020 . 1.1 54.3 50.9
Age: 16 to 19 years Upper bound 95% confidence interval 2021 . 2.5 54.9 49.7
Age: 20 to 29 years Value 2014 0.0 0.7 . .
Age: 20 to 29 years Value 2015 0.0 0.6 . .
Age: 20 to 29 years Value 2016 0.1 0.3 . .
Age: 20 to 29 years Value 2017 0.0 0.3 . .
Source: CBS.
Explanation of symbols

Dataset is not available.


This table contains data on the perceived state of health and on contacts with providers of medical care of the Dutch population in private households. These data can be grouped by several personal characteristics.

Data available for 2014-2021

Status of the data: final.

Changes as of July 31, 2023:
None, the table has been discontinued.

When will new data be published?
Not applicable. This table has been replaced, see paragraph 3 for a link to the new table.

Description topics

Chronic disorders
All respondents are asked: ꞌDo you /Does your child have one or more chronic disorders?ꞌ Chronic means (in anticipation) 6 months or longer. Next, 23 disorders and a remainder category 'other disorders' are presented and persons are asked if they had this disorder during the last 12 months. Persons are asked after 3 of these disorders if they ever suffered from it. Besides (more elaborately) is asked after diabetes. Most questions on specific chronic disorders are being asked to persons of all ages. Questions on disorders that do not occur amongst youngsters are posed to persons of 12 years or older.
Disorders in the last 12 months
Chronic diseases/disorders in the last 12 months. Respondents may currently suffer from the disease/disorder or have suffered from it in the last 12 months.
Stroke, cerebral haemorrhage/infarction
Percentage of persons of 12 years or older who answered ꞌyesꞌ to the question: ꞌHave you ever suffered from a stroke, cerebral haemorrhage or cerebral infarction?ꞌ And ꞌyesꞌ to the question: ꞌDid you have this in the last 12 months?'
Chronic disorders, ever had
This concerns 3 chronic disorders/diseases respondents have ever suffered from.
Stroke, cerebral haemorrhage/infarction
Percentage of persons of 12 years or older who answered ꞌyesꞌ to the question: ꞌHave you ever had a stroke, cerebral haemorrhage or cerebral infarction?'
SF-12 health measure, age 12 or older
The 'Short Format 12' or SF-12 questionnaire is a selection of 12 questions from the SF-36 (Ware et al., 1995 *). The SF-12 is a widely used international standard of a generic health measure. The SF-12 measures eight health aspects, namely physical functioning, role limitations due to physical health problems, physical pain, general health, vitality (energy / fatigue), social functioning, role limitations due to emotional problems and mental health. Based on the 12 questions, two partial scales can be calculated; a summary measure for physical health (norm score physical) and a summary measure for psychological health (norm score psychological).
These norm scores are calculated for people aged 12 or older.
*Ware J.E., Kosinski M., Keller S.D. SF-12: How to score the SF-12 Physical and Mental Health Summary Scales. Boston, MA: The Health Institute, New England Medical Center, Second Edition, 1995.
Norm score physical
Standard score physical is determined for persons 12 years of age or older. The standard score physical is a summary physical health measure, which is calculated by means of the answers to the SF-12 questionnaire. The American population was used as the reference group in the development of the norm scores. In 1995, the physical health score for the American population was exactly 50. Mean values below 50 indicate less good physical health than in that standard population (American population 1995) and values above 50 indicate better health. For the Dutch population, the average of the physical norm score is slightly higher than 50.
Norm score Psychological
Psychological norm score is determined for people aged 12 or older. The psychological norm score is a summary psychological health measure, which is calculated by means of the answers to the SF-12 questionnaire. The American population was used as the reference group in the development of the norm scores. In 1995, the psychological health score of the American population was exactly 50. Mean values below 50 indicate less good psychological health than in that standard population (American population 1995) and values above 50 indicate better health. For the Dutch population, the average of the psychological norm score is slightly higher than 50.